Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.130
+0.100 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.070
-0.060 (-1.92%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Xenetic Biosciences Employees
Xenetic Biosciences had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,488,206
Profits / Employee
-$1,340,430
Market Cap
7.17M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| FibroBiologics | 15 |
| Immuron | 7 |
| Akari Therapeutics, | 6 |
| Can-Fite BioPharma | 5 |
| Acurx Pharmaceuticals | 4 |
| Silo Pharma | 3 |
| Addex Therapeutics | 2 |
XBIO News
- 6 days ago - Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting - Accesswire
- 6 weeks ago - Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results - Accesswire
- 3 months ago - Xenetic Biosciences Transcript: AGM 2025 - Transcripts
- 4 months ago - Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - Accesswire
- 5 months ago - Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform - Accesswire
- 5 months ago - Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results - Accesswire
- 7 months ago - Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock - Accesswire
- 9 months ago - Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results - Accesswire